You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
The project will result in the creation of a national cohort for research, as well as an integrated clinical and genomic data infrastructure at the national level.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
To support the 1+ Million Genomes Initiative, the EC has funded a new project, called Beyond 1 Million Genomes, with €4 million over the next three years.
Reveal Genomics plans to have assays available within three years, and is eager to partner with pharmaceutical and diagnostics companies to fulfill its vision.
Driving the shift is a belief that standard STR testing is not always a reliable tool for determining complex family relationships.
The companies are positioning the test, called SeptiCyte Rapid, for use in triaging COVID-19 patients who could be at greater risk for progressing to sepsis.
The service is the first of its kind in the UK and relies on the Illumina NovaSeq 6000 platform to deliver results.
The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.
The Oslo-based company plans to develop a test that can identify high-risk individuals based on an epigenetic signature.
The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.
A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.
The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.
In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.